Skip to Primary Navigation

Skip to main content

DOJ strikes twice over False Claims Act allegations and cybersecurity lapses

Image is of the Illumina corporate headquarters and signage.
Photo: Justin Sullivan/Getty Images

Julie DiMauro

3 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Failing to meet cybersecurity standards and offering misleading statements about meeting them can lead to penalties for government contractors.

The US Department of Justice (DOJ) has announced a $9.8m settlement with Illumina, known for its work in DNA sequencing and other technologies, citing allegations that the company sold genomic-sequencing systems with software vulnerabilities to federal agencies for multiple years.

The case against the biotech company specializing in

, , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience